McCormick & Co. Inc. (MKC)

102.32
NYSE : Consumer Non-Durables
Prev Close 102.32
Day Low/High 0.00 / 0.00
52 Wk Low/High 90.25 / 111.46
Avg Volume 963.30K
Exchange NYSE
Shares Outstanding 121.28M
Market Cap 13.50B
EPS 3.80
P/E Ratio 16.71
Div & Yield 2.08 (1.92%)

Latest News

Income Seeker: American Water Works Can Quench Your Thirst for Dividends

The stock has a 2.19% dividend that’s well-covered and rises over time.

McCormick Honors 2018 Unsung Heroes

Charles Perry McCormick Scholarships Awarded to Jamar Mackell of Mergenthaler Vo-Tech High School and Natalie Bates of Eastern Technical High School; McCormick Distributes $105,000 in Total Scholarships

Trifecta Stocks Weekly Roundup

During a mixed week for the market we scaled into a handful of positions including our inverse ETF names.

McCormick Makes 2018 DiversityInc Top 50 List

Diversity and Inclusion Efforts and Belief in the Power of People Driving Strong Culture

Trifecta Stocks Weekly Roundup

While the market traded slightly lower for the week, Trifecta holding Amazon popped on blowout earnings.

Trifecta Stocks Weekly Roundup

A number of our positions are easily outperforming the market this quarter even after the late-week fade.

Trifecta Stocks Weekly Roundup

Alongside the market’s move higher this week and the kickoff of another earnings season, shares of nearly all of our positions increased.

Where (and How) to Find 'Dividend Aristocrats'

Where (and How) to Find 'Dividend Aristocrats'

The Nasdaq U.S. Broad Dividend Achievers Index is a good place to start.

Trifecta Stocks Weekly Roundup

While market swings certainly had an impact on the portfolio, we still had several outperformers on a relative basis this week.

Income Seeker: Where (and How) to Find 'Dividend Aristocrats'

The Nasdaq U.S. Broad Dividend Achievers Index is a good place to start.

Trifecta Stocks Weekly Roundup

We removed one position from the portfolio this week as the market closed out a tumultuous quarter.

McCormick’s Chart Is Getting Spicy

If MKC pulls back to the 200-day moving average, it would be another buy opportunity.

The Dow Plunges Into the Close of Trading on Tuesday

The Dow Plunges Into the Close of Trading on Tuesday

Cooling tensions with China aren't enough to save investors on Tuesday.

Jim Cramer: A Hideous Day for Lots of Stocks

Jim Cramer: A Hideous Day for Lots of Stocks

But the Dow stocks keep making up for lost ground from Thursday and Friday.

Facebook, Novartis, GSK, Uber and Deutsche Bank - 5 Things You Must Know

Facebook, Novartis, GSK, Uber and Deutsche Bank - 5 Things You Must Know

U.S. stock futures rise and global stocks extend their rally; Novartis to sell 36.5% stake in joint venture to partner GSK for $13 billion; Facebook's Mark Zuckerberg won't face U.K. lawmakers.

Thank Goodness It's Friday: Cramer's 'Mad Money' Recap (Friday 3/23/18)

Thank Goodness It's Friday: Cramer's 'Mad Money' Recap (Friday 3/23/18)

With the stock market averages swinging wildly, Jim Cramer has your game plan for next week.

Trifecta Stocks Weekly Roundup

We exited one position this week as the market declined on an overflowing plate of items to digest.

Packaged Food Stocks Look Like a Terrible Investment: Wall Street Firm

Packaged Food Stocks Look Like a Terrible Investment: Wall Street Firm

Eroding margins, pressure from Walmart and diminished pricing power makes investors skeptical of packaged food stocks, analysts say.

Next Week's Market Game Plan: Cramer's 'Mad Money' Recap (Friday 3/16/18)

Next Week's Market Game Plan: Cramer's 'Mad Money' Recap (Friday 3/16/18)

Mixed in with all these negatives and uncertainties, there are great earnings -- and earnings are what investors need to focus on. Here's your game plan for next week.

Trifecta Stocks Weekly Roundup

A quant downgrade forced us to exit one position but we added three new names as the market drifted lower.

Trifecta Stocks Weekly Roundup

As the market rallied late this week, so did a number of our positions, leaving more than half the portfolio outperforming the S&P year to date.

Trifecta Stocks Weekly Roundup

This week, we prudently trimmed one position and used the proceeds to scale into two others as President Trump’s tariff announcement roiled the markets.

Trifecta Stocks Weekly Roundup

It was another good week for the portfolio, with the majority of our positions outperforming the major indices.

Why Albertsons Is Buying Rite Aid and How We Are Playing It

Breaking down the merger details and what it means for Rite Aid and the portfolio’s position.

Trifecta Stocks Weekly Roundup

We added a new position this week as a sharp rebound in the overall market led to pronounced moves higher in the Trifecta portfolio.

TheStreet Quant Rating: A (Buy)